Log in to search using one of your social media accounts:

NIH announces network to accelerate medicines for rheumatoid arthritis and lupus
Partnership includes support from industry and non-profits. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - September 24, 2014 Category: American Health Source Type: news

NIH announces network to accelerate medicines for rheumatoid arthritis and lupus
(NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases) The National Institutes of Health has awarded grants to 11 research groups across the United States to establish the Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus Network. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 24, 2014 Category: Global & Universal Source Type: news

Efficacy and Safety of Golimumab as Add-on Therapy to DMARDsEfficacy and Safety of Golimumab as Add-on Therapy to DMARDs
How safe and effective is subcutaneous golimumab as an add-on therapy in patients with active rheumatoid arthritis? Annals of the Rheumatic Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 22, 2014 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

The incidence and risk factors for falls in adults with rheumatoid arthritis: A systematic review - Brenton-Rule A, Dalbeth N, Bassett S, Menz HB, Rome K.
OBJECTIVE: To conduct a systematic review of the incidence and risk factors for falls in people with rheumatoid arthritis (RA). METHODS: A search was conducted of the electronic databases AMED, CINAHL, MEDLINE, Scopus and The Cochrane Library. Stud... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - September 20, 2014 Category: Global & Universal Tags: Age: Elder Adults Source Type: news

Adding Chinese Herb to Methotrexate May Help Ease Active RAAdding Chinese Herb to Methotrexate May Help Ease Active RA
Patients with active rheumatoid arthritis (RA) may benefit from treatment with Tripterygium wilfordii Hook F (TwHF) and methotrexate (MTX), new research from China suggests. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 18, 2014 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Tampered Vials of Roche Injectable Cancer Drug Found in Germany
A German drug distributor has discovered three vials of Roche's cancer and rheumatoid-arthritis drug MabThera with evidence of tampering. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 16, 2014 Category: Pharmaceuticals Source Type: news

Salty Foods May Double Smokers' Risk of Rheumatoid Arthritis
Title: Salty Foods May Double Smokers' Risk of Rheumatoid ArthritisCategory: Health NewsCreated: 9/12/2014 12:36:00 PMLast Editorial Review: 9/15/2014 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - September 15, 2014 Category: Rheumatology Source Type: news

Salty Foods May Double Smokers' Risk of Rheumatoid Arthritis
About half of raised risk from tobacco tied to interaction with too much sodium, study finds (Source: WebMD Health)
Source: WebMD Health - September 12, 2014 Category: Consumer Health News Source Type: news

Salty Foods May Double Smokers' Risk of Rheumatoid Arthritis
About half of raised risk from tobacco tied to interaction with too much sodium, study finds Source: HealthDay Related MedlinePlus Pages: Dietary Sodium, Rheumatoid Arthritis, Smoking (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - September 12, 2014 Category: Consumer Health News Source Type: news

No innocent bystander: Cartilage contributes to arthritis
Cartilage plays an active role in the destruction and remodeling of joints seen in rheumatoid arthritis, rather than being an 'innocent bystander' as previously thought, researchers report. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 12, 2014 Category: Science Source Type: news

Director's Comments: NIH MedlinePlus Magazine Summer 2014
Listen to the NLM Director's Comments on "NIH MedlinePlus Magazine Summer 2014". The transcript is also available. The new edition of NIH MedlinePlus Magazine Summer 2014 covers rheumatoid arthritis, eye health, as well as information about breast cancer... (Source: What's New on MedlinePlus)
Source: What's New on MedlinePlus - September 11, 2014 Category: Consumer Health News Source Type: news

No innocent bystander: Cartilage contributes to arthritis
(Walter and Eliza Hall Institute) Melbourne researchers have discovered that cartilage plays an active role in the destruction and remodeling of joints seen in rheumatoid arthritis, rather than being an 'innocent bystander' as previously thought. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - September 11, 2014 Category: Biology Source Type: news

Shingles Risks Similar for the RA Biologics
(MedPage Today) -- The risk of developing herpes zoster was similar among older patients with rheumatoid arthritis (RA) treated with the various different biologic agents, a retrospective study found. (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - September 11, 2014 Category: Rheumatology Source Type: news

Blocking single receptor could halt rheumatoid arthritis
Researchers have shown for the first time how the activation of a receptor provokes the inflammation and bone degradation of rheumatoid arthritis -- and that activation of this one receptor, found on cells in the fluid of arthritic joints, is all that is required. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 10, 2014 Category: Science Source Type: news

Smokers who consume too much sodium at greater risk of developing rheumatoid arthritis
(Oxford University Press) A new study published online in the journal Rheumatology today indicates that the interaction between high sodium intake and smoking is associated with a more than doubled risk of developing rheumatoid arthritis. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - September 10, 2014 Category: Global & Universal Source Type: news

Jim Sullivan on Improving the Lives of Patients
At AbbVie, research and innovation are the cornerstones of our business as a global biopharmaceutical company. We focus on developing medicines that deliver strong clinical performance, provide more patient benefit and deliver economic value, particularly where there is significant need around the world in certain disease areas.  Arthritis is an example of a disease where we have the opportunity to continue to make headway to improve the lives of patients. According to the U.S. Centers for Disease Control and Prevention (CDC) prevalence of musculoskeletal diseases could increase from 52 million people in the U.S. to 6...
Source: PHRMA - September 9, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news

Roche's rheumatoid arthritis drug wins EU approval for extended use
ZURICH (Reuters) - Swiss drugmaker Roche Holding AG said on Monday the European Union has approved the use of its drug RoActemra in patients with early-stage rheumatoid arthritis. (Source: Reuters: Health)
Source: Reuters: Health - September 8, 2014 Category: Consumer Health News Tags: healthNews Source Type: news

Roche's RoACTEMRA receives EU approval for use in patients with early rheumatoid arthritis (RA)
Roche announced today that RoACTEMRA (tocilizumab) has received approval from the European Commission for use in patients with severe, active and progressive RA who previously have not been treated with methotrexate (MTX). Treating the disease at this critical early phase may prevent irreversible damage to joints and long-term disability.1,2 RoACTEMRA is the first interleukin-6 (IL-6) receptor antagonist to be approved for use in Europe in patients with early RA. (Source: Roche Media News)
Source: Roche Media News - September 8, 2014 Category: Pharmaceuticals Source Type: news

Roche's RoACTEMRA receives EU approval for use in patients with early rheumatoid arthritis (RA)
Roche announced today that RoACTEMRA (tocilizumab) has received approval from the European Commission for use in patients with severe, active and progressive RA who previously have not been treated with methotrexate (MTX). Treating the disease at this critical early phase may prevent irreversible damage to joints and long-term disability. RoACTEMRA is the first interleukin-6 (IL-6) receptor antagonist to be approved for use in Europe in patients with early RA. (Source: Roche Investor Update)
Source: Roche Investor Update - September 8, 2014 Category: Pharmaceuticals Source Type: news

RheumShorts: HCV Complicates RA Treatment, Outcomes (CME/CE)
(MedPage Today) -- New studies examined the effects of hepatitis C virus infection in patients with rheumatoid arthritis and socioeconomic status on juvenile idiopathic arthritis, and a report from Finland traced an outbreak of foodborne disease and reactive arthritis. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - September 5, 2014 Category: Geriatrics Source Type: news

RA: Effect of 'Complete Disease Control' on Pain, FunctionRA: Effect of 'Complete Disease Control' on Pain, Function
Patients with rheumatoid arthritis who have more complete disease control had better outcomes than those who did not. Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - September 4, 2014 Category: Rheumatology Tags: Rheumatology News Source Type: news

Many Rheumatoid Arthritis Patients May Skip Meds: Study
Title: Many Rheumatoid Arthritis Patients May Skip Meds: StudyCategory: Health NewsCreated: 9/3/2014 5:35:00 PMLast Editorial Review: 9/4/2014 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - September 4, 2014 Category: Rheumatology Source Type: news

Many Rheumatoid Arthritis Patients May Skip Meds: Study
This could lead to worsening of symptoms, researchers say (Source: WebMD Health)
Source: WebMD Health - September 3, 2014 Category: Consumer Health News Source Type: news

Treat-to-Target With Actemra Succeeds in RA
(MedPage Today) -- Treating rheumatoid arthritis with tocilizumab (Actemra) only until remission was achieved allowed many patients to achieve sustained remission, and some were able to stop treatment altogether for short periods. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - September 3, 2014 Category: Primary Care Source Type: news

Many Rheumatoid Arthritis Patients May Skip Meds
This could lead to worsening of symptoms, researchers say Source: HealthDay Related MedlinePlus Pages: Medicines, Rheumatoid Arthritis (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - September 3, 2014 Category: Consumer Health News Source Type: news

How to Get in the Mood for Sex When You Have RA
If you have rheumatoid arthritis, sex can ease pain, lift your spirits, and keep you connected to your partner. So don't avoid sex -- just take a little extra care to make it feel good. Here's how. (Source: WebMD Health)
Source: WebMD Health - September 3, 2014 Category: Consumer Health News Source Type: news

Rheumatoid Arthritis: Test Your Arthritis IQ
Title: Rheumatoid Arthritis: Test Your Arthritis IQCategory: MedicineNet QuizCreated: 1/31/2011 5:38:00 PMLast Editorial Review: 9/3/2014 12:49:27 PM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - September 3, 2014 Category: Rheumatology Source Type: news

RA: Publication Bias Alive and Well
(MedPage Today) -- Randomized trials of treatments for rheumatoid arthritis with positive outcomes have remained more likely to be published than those with negative results, despite the establishment of ClinicalTrials.gov. (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - August 28, 2014 Category: American Health Source Type: news

Rheumatoid Arthritis: Living With a Chronic Disease
Title: Rheumatoid Arthritis: Living With a Chronic DiseaseCategory: Doctor's & Expert's views on SymptomsCreated: 1/19/2012 7:09:00 PMLast Editorial Review: 8/28/2014 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - August 28, 2014 Category: Rheumatology Source Type: news

Patient Story: Rheumatoid Arthritis Treatment
Title: Patient Story: Rheumatoid Arthritis TreatmentCategory: Doctor's & Expert's views on SymptomsCreated: 1/20/2012 7:03:00 PMLast Editorial Review: 8/28/2014 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - August 28, 2014 Category: Rheumatology Source Type: news

Cognitive-behavioral coping skills training has positive effects on rheumatoid arthritis
Two psychological interventions have been separately and in combination been studied to determine their effectiveness in offering relief to RA patients. Cognitive-behavioral coping skills training trains patients in various cognitive and behavioral techniques or skills to enhance their ability to cope with pain and improve their behavioral and psychological functioning. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 23, 2014 Category: Science Source Type: news

Creating pomegranate drug to stem Alzheimer's, Parkinson's
Research will look to produce compound derivatives of punicalagin for a drug that would treat neuro-inflammation and slow down the progression of Alzheimer's disease, scientists report. The onset of Alzheimer's disease can be slowed and some of its symptoms curbed by a natural compound that is found in pomegranate. Also, the painful inflammation that accompanies illnesses such as rheumatoid arthritis and Parkinson's disease could be reduced, according to the findings of the two-year project. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 22, 2014 Category: Science Source Type: news

Research underway to create pomegranate drug to stem Alzheimer's and Parkinson's
(University of Huddersfield) The onset of Alzheimer's disease can be slowed and some of its symptoms curbed by a natural compound that is found in pomegranate. Also, the painful inflammation that accompanies illnesses such as rheumatoid arthritis and Parkinson's disease could be reduced, according to the findings of a two-year project headed by University of Huddersfield scientist Dr. Olumayokun Olajide, who specialises in the anti-inflammatory properties of natural products. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 22, 2014 Category: Global & Universal Source Type: news

Study shows cognitive-behavioral coping skills training has positive effects on rheumatoid arthritis
(Wayne State University - Office of the Vice President for Research) A team of researchers from Wayne State University and collaborators from Duke University Medical Center recently published a paper in the Journal of Consulting and Clinical Psychology that explores two psychological interventions separately and in combination to determine their effectiveness in offering relief to rheumatoid arthritis patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 22, 2014 Category: Global & Universal Source Type: news

RheumShorts: Allipurinol, Autoantibodies in RA (CME/CE)
(MedPage Today) -- The rheumatology literature this week featured studies on allopurinol and severe cutaneous adverse reactions, the additive effects of autoantibodies on bone erosions in rheumatoid arthritis, and predicting response to methotrexate in children with juvenile idiopathic arthritis. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - August 20, 2014 Category: Primary Care Source Type: news

RheumShorts: Allopurinol; Autoantibodies in RA (CME/CE)
(MedPage Today) -- The rheumatology literature this week featured studies on allopurinol and severe cutaneous adverse reactions, the additive effects of autoantibodies on bone erosions in rheumatoid arthritis, and predicting response to methotrexate in children with juvenile idiopathic arthritis. (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - August 20, 2014 Category: Rheumatology Source Type: news

BrCa Risk Stable With Anti-TNF Tx
(MedPage Today) -- Women with rheumatoid arthritis and a history of breast cancer had no increased risk of cancer recurrence if treated with anti-tumor necrosis factor therapy, Swedish researchers reported. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - August 18, 2014 Category: Geriatrics Source Type: news

TNF Inhibitors for RA: No Link to Breast CancerTNF Inhibitors for RA: No Link to Breast Cancer
Swedish researchers have found no link between TNF inhibitors used to treat rheumatoid arthritis and breast cancer recurrence. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 18, 2014 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Response to Rituximab in RA Not Altered by StatinsResponse to Rituximab in RA Not Altered by Statins
Statins do not appear to alter the response to rituximab significantly in patients with rheumatoid arthritis, according to new research. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 15, 2014 Category: Consumer Health News Tags: Rheumatology News Source Type: news

National Psoriasis Foundation on Improving the Lives of Patients
Millions of Americans with psoriatic arthritis—a serious disease that causes pain, swelling and stiffness of the joints and tendons, and can result in joint damage if left untreated—struggle to get the health care and treatments they need to manage their condition. National Psoriasis Foundation plans to change with the largest realignment and expansion of its psoriatic arthritis program. For nearly two decades, the Psoriasis Foundation has provided disease-management services and information to people with psoriatic arthritis (PsA), which affects as many as one in three people with psoriasis, the most common au...
Source: PHRMA - August 13, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news

Understanding Rheumatoid Arthritis Medications
Rheumatoid Arthritis Medications (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - August 13, 2014 Category: Journals (General) Source Type: news

Mayo Clinic News Network — Headlines 8/13/14
http://youtu.be/jZe10TqaOoI Mayo Clinic News Network Headlines include: Prescription drugs online Early diagnosis of rheumatoid arthritis Choosing sunscreen Journalists: Video is available in the downloads. Click here for script. (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - August 13, 2014 Category: Databases & Libraries Source Type: news

'Worm pill' could ease autoimmune disease symptoms
Experts believe a molecule in parasitic worms could help explain why worm infections can effectively treat a range of autoimmune diseases, including multiple sclerosis, psoriasis, rheumatoid arthritis and lupus. The study successfully identified peptides from parasitic worms that suppress the body's immune response. Researchers believe this could pave the way for a new drug containing the peptide to provide relief from the symptoms of autoimmune diseases. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 11, 2014 Category: Science Source Type: news

RheumShorts: IL-6 and RA, Life and Death, Surgery in Lupus (CME/CE)
(MedPage Today) -- The September issue of the Annals of the Rheumatic Diseases featured studies on an investigational interleukin-6 inhibitor for rheumatoid arthritis, mortality effects of early remission in inflammatory arthritis, and adverse surgical outcomes for patients with lupus. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - August 6, 2014 Category: Geriatrics Source Type: news

Toward Personalized Medicine for Kidney Transplant Recipients
UC San Francisco is the lead institution on a new seven-year, $17 million multicenter study funded by the National Institutes of Health to determine if certain immune system cells and/or a drug now used for treating rheumatoid arthritis can be effective in improving and maintaining the long-term health of kidney transplant recipients. (Source: UCSF Medical Center)
Source: UCSF Medical Center - August 5, 2014 Category: Universities & Medical Training Authors: webservices at ucsfhealth.org Source Type: news

Gabriela Lavezzari on Improving the Lives of Patients with Arthritis
Many people are unaware of the impact of arthritis and related musculoskeletal diseases in the United States. They affect approximately 52.5 million Americans of all ages, races and genders. The biopharmaceutical industry is making great strides towards new treatments with 92 medicines in the pipeline which have the potential to help patients live more active and productive lives. Work on these treatments is more imperative than ever as 67 million people could be diagnosed with some form of musculoskeletal disease by 2030, according to the U.S. Centers for Disease Control and Prevention. Earlier this year, PhRMA joined 10...
Source: PHRMA - August 4, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news

Toward personalized medicine for kidney transplant recipients
(University of California - San Francisco) UC San Francisco is the lead institution on a new seven-year, $17 million multicenter study funded by the National Institutes of Health to determine if certain immune system cells and/or a drug now used for treating rheumatoid arthritis can be effective in improving and maintaining the long-term health of kidney transplant recipients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 4, 2014 Category: Global & Universal Source Type: news

Prevalence of falls in fibromyalgia patients - Meireles SA, Antero DC, Kulczycki MM, Skare TL.
OBJECTIVE: To compare the risk of falls in fibromyalgia (FM) patients compared to rheumatoid arthritis (RA) patients and normal controls. METHODS: We studied 60 FM, 60 RA patients and 60 controls for fall frequency in one week, one month, six month... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - August 3, 2014 Category: Global & Universal Tags: Falls Source Type: news

Obesity in Women Linked With Early RA
(MedPage Today) -- Women who are overweight or obese, particularly those becoming so by late adolescence, have an elevated risk for developing rheumatoid arthritis. (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - August 1, 2014 Category: Endocrinology Source Type: news

Frontier Pharma Rheumatoid Arthritis Identifying and Commercializing...
Market Resarch Reports.Biz include new market research report "Frontier Pharma - Rheumatoid Arthritis: Identifying and Commercializing First-in-Class Innovation" to its huge collection of...(PRWeb July 30, 2014)Read the full story at http://www.prweb.com/releases/2014/07/prweb12047446.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 31, 2014 Category: Pharmaceuticals Source Type: news